Moreover, mutations or alterations in GRIN3A/Grin3a expression in humans and mice are linked to diverse neurological conditions such as schizophrenia, bipolar disorder, addiction, epilepsy, and Huntington’s disease making GluN3A an attractive candidate for therapeutic intervention 13,32–39. Here, GRIN3A is linked to schizophrenia.